Legal Affairs

Cresco Labs Reports Q1 2026 Financial Results

CHICAGO – Cresco Labs Inc. released its first-quarter results, showcasing the ongoing efforts of one of the largest MSOs to strengthen operations across its footprint while preparing for potential changes at the federal level. With ...

Cronos Group Reports Q1 2026 Financial Results

TORONTO – Cronos Group Inc. posted record net revenue and gross profit for the first quarter of 2026, driven by higher sales volumes, a favorable product mix, and gains in key markets. The Cannabis company ...

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – The past two weeks brought measurable movement across federal policy, corporate financial reporting, international deals, and product categories in the U.S. Cannabis sector. Operators absorbed details on rescheduling implications, watched hemp-derived THC ...

BREAKING: DOJ Signs Cannabis into Schedule III

WASHINGTON – Today, the federal government took its most consequential step on Cannabis policy in decades, as Acting Attorney General Todd Blanche formally signed an order moving state-licensed medical Cannabis from Schedule I to Schedule ...

Safe Harbor Targets Retirement Gap in Cannabis Workforce

DENVER – Safe Harbor Financial is extending its reach deeper into workforce benefits, introducing a pooled employer 401(k) plan designed for Cannabis operators that have long struggled to access conventional retirement services. The new offering, ...

Cresco Labs Reports Q1 2026 Financial Results

CHICAGO – Cresco Labs Inc. released its first-quarter results, showcasing the ongoing efforts of one of the largest MSOs to strengthen operations across its footprint while preparing for potential changes at the federal level. With ...

Cronos Group Reports Q1 2026 Financial Results

TORONTO – Cronos Group Inc. posted record net revenue and gross profit for the first quarter of 2026, driven by higher sales volumes, a favorable product mix, and gains in key markets. The Cannabis company ...

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – The past two weeks brought measurable movement across federal policy, corporate financial reporting, international deals, and product categories in the U.S. Cannabis sector. Operators absorbed details on rescheduling implications, watched hemp-derived THC ...

High-Potency Cannabis Strains Impact Legal and Health Systems

LOS ANGELES— The expansion of high-potency cannabis products—such as concentrated extracts, edibles, and potent vaping liquids is increasingly challenging health-care facilities and legal systems across North America. Emergency departments in the U.S. and Canada report ...

New Zealand Approves Psilocybin for Medicinal Use

LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use ...

MJ and MSOS ETFs Signal High Upside on U.S. Legalization Outlook

LOS ANGELES- Investment in cannabis-focused ETFs such as Amplify’s MJ and AdvisorShares’ MSOS reflects growing investor anticipation of federal legalization-driven expansion, even amid pronounced volatility and structural headwinds. Analysts argue that rescheduling cannabis from Schedule I ...

Canadian Cannabis Producers Expand Exports

LOS ANGELES- Canada’s licensed cannabis sector continues its move toward international markets, driven by strong global demand, especially for medical cannabis. During the 2023–24 fiscal year, Canada exported approximately CA$218 million of medical cannabis for commercial ...

Emerging Programs Aim to Democratize Cannabis Cultivation

LOS ANGELES- Governments, industry groups, and educational institutions are launching a wave of initiatives aimed at lowering barriers to entry in cannabis cultivation and production—efforts collectively referred to as “democratizing cannabis production.” These programs focus ...

Subscribe To Our Newsletter